A randomised trial comparing the safety and efficacy of the Zoladex 10.8 mg depot, administered every 12 weeks, to that of the Zoladex 23,6 mg depot, administered every 4 weeks, in patients with advanced prostate cancer
Autor: | Dijkman, G.A., Debruyne, F.M.J., Fernandez del Moral, P., Plasman, J.W.M.H., Hoefakker, J.W., Idema, J.G., Sykes, M. |
---|---|
Jazyk: | angličtina |
Rok vydání: | 1995 |
Zdroj: | Medisch Contact, 27, 1, pp. 43-46 Medisch Contact, 27, 43-46 |
ISSN: | 0025-8245 |
Popis: | Item does not contain fulltext |
Databáze: | OpenAIRE |
Externí odkaz: |